This inventor holds 10 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignee: The State University of New York. Active years: 2010-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2026
Title: Sathy Balu-Iyer: Innovator in Immune Tolerance Induction
Introduction
Sathy Balu-Iyer is a prominent inventor based in Amherst, NY (US). He has made significant contributions to the field of immunology, particularly in the area of immune tolerance induction. With a total of 10 patents to his name, Balu-Iyer's work has the potential to impact therapeutic approaches for various diseases.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Phosphoserine containing compositions for immune tolerance induction." This patent discloses compositions and methods for inducing immune tolerance to proteins, along with the subsequent administration of these proteins. The compositions comprise proteins complexed with liposomes that include phosphoserine (PS) and phosphatidylcholine (PC), wherein at least part of the PS is present as lyso-PS. This innovative approach could pave the way for new treatments in immunotherapy.
Career Highlights
Sathy Balu-Iyer is affiliated with the State University of New York, where he continues to advance his research and development efforts. His academic and professional journey has been marked by a commitment to exploring the complexities of immune responses and developing novel therapeutic strategies.
Collaborations
Balu-Iyer has collaborated with notable colleagues, including Richard Bankert and Robert M Straubinger. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in immunology.
Conclusion
Sathy Balu-Iyer's contributions to the field of immune tolerance induction exemplify the impact of innovative research on healthcare. His patents and collaborations reflect a dedication to advancing scientific knowledge and improving therapeutic outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

